Navigation Links
Schering-Plough Reports Financial Results for 2009 First Quarter
Date:4/21/2009

ewer markets, adding new therapeutic areas, creating a leading global animal health business, and growing the consumer business through successful Rx-to-OTC switches;
  • Increasing the number of marketed products with sales above $1 billion from none in 2003 to five in 2008 (REMICADE, NASONEX and TEMODAR - as well as VYTORIN and ZETIA in the cholesterol joint venture);
  • Adding more than $12 billion to adjusted net sales, from $8.6 billion in 2003 to $20.8 billion in 2008;
  • Strengthening the company's financial position, going from negative free cash flow of nearly $1 billion in 2003 to generating positive free cash flow of more than $2 billion in 2008;
  • Successfully seeking, negotiating and integrating important and value-creating transactions, such as the acquisition of Organon BioSciences (OBS).

  • First Quarter 2009 Results

    For the 2009 first quarter, Schering-Plough reported net income available to common shareholders of $767 million or 46 cents per common share on a GAAP basis. Earnings per common share for the 2009 first quarter would have been 56 cents on earnings of $936 million on a reconciled basis, which excludes purchase accounting adjustments related to the OBS acquisition and special, merger and acquisition-related items. For the 2008 first quarter, Schering-Plough reported net income available to common shareholders of $276 million or 17 cents per common share on a GAAP basis and earnings of 53 cents per common share on a reconciled basis.

    GAAP net sales for the 2009 first quarter totaled $4.4 billion, down 6 percent as compared to the first quarter of 2008, reflecting 4 percent operational growth and an unfavorable impact from foreign exchange of 10 percent.

    Net sales of the cholesterol franchise, which include sales of the cholesterol joint venture plus sales recorded by Schering-Plough in
    '/>"/>

    SOURCE Schering-Plough Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine news :

    1. EPA Names Schering-Plough 2009 EPA ENERGY STAR(R) Partner of the Year
    2. Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M.
    3. Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
    4. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
    5. Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
    6. Schering-Plough Selects Benefit Advocates for Health Advocacy
    7. Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
    8. Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
    9. Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R)
    10. Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
    11. Schering-Plough to Webcast R&D Update Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... 31, 2014 In its latest blog post, ... believes that having family close by during a stay in ... the process is successful, is looking at 10 tips to ... , “Addiction recovery is a lifelong process, and one that ... committed to without compromise,” commented Best Drug Rehabilitation’s CEO ...
    (Date:7/31/2014)... 2014 The study, The Truth ... Medicare episode of care payments for four clinical areas—congestive ... joint replacements (hips and knees). Using the definition ... for Care Improvement program, the study examines these clinical ... in the country. , “Our study reaffirms that, in ...
    (Date:7/30/2014)... The Mesothelioma Applied Research Foundation ... Center, will host a regional conference on ... field of mesothelioma. September 26 marks the National Mesothelioma ... the public, and specifically aimed at mesothelioma patients, family ... exposed to asbestos. , The conference will take place ...
    (Date:7/30/2014)... Regardless of traumatic events experienced during deployment, returning ... a drinking problem if faced with civilian life ... serious financial and legal problemsall commonplace in military ... Columbia University,s Mailman School of Public Health are ... Preventive Medicine . , Alcohol abuse is a ...
    (Date:7/30/2014)... “United States Orthopedic Braces and Supports Market Outlook to 2020?, ... and Supports market. The report provides value, in millions of ... (in US dollars), within market categories:, ... Supports , Spinal Braces and Supports , ... is a specialty within the medical field concerned with the ...
    Breaking Medicine News(10 mins):Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 2Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 3Health News:Vets' alcohol problems linked to stress on the home front 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 3Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 4
    ... Healthcare and personal care items shipped to QualComm Stadium and other ... for distribution to evacuees, Prescription delivery service from CVS to Qualcomm ... ... filled, WOONSOCKET, R.I., Oct. 24 CVS/pharmacy, the retail,division of CVS Caremark ...
    ... good to eat," they,re hoping for candy -- and ... but also a tradition that causes,concern about the effects ... and common sense, however, parents can help protect their ... of sugar in Halloween candy is stunning," said Dr. ...
    ... early gained some symptom relief, study found , , WEDNESDAY, ... month,s worth of inhaler medicine may have lessened rescue ... 11, 2001, World Trade Center attacks, according to new ... anti-inflammatory medicines commonly used for the treatment of asthma. ...
    ... Washington, D.C.More than three quarters of adults living in ... factor for stroke, but those who are poor do ... wealthier counterparts. In an effort to address these disparities ... NIH,s National Institute of Neurological Disorders and Stroke (NINDS) ...
    ... advice in approaching decisions about life, career, having a ... of the Institute for Operations Research and the Management ... Research Professor of Decision Sciences at the Fuqua School ... A Practical Guide to Making Better Decisions, a Harvard ...
    ... messages from meaningless noise could be an early sign ... of Medicine researchers. , The study this month in ... diagnosed with prodromal symptoms meaning they exhibited early warning ... alterations, or misinterpretation of social cues. , Participants in ...
    Cached Medicine News:Health News:CVS/pharmacy Donates More Than $300,000 in Supplies to Aid Fire Relief Efforts in California 2Health News:Parents: With Halloween Candy, Focus on Choice and Time to Prevent Teeth Decay 2Health News:Inhaler Eased Lung Problems in 9/11 Workers 2Health News:Inhaler Eased Lung Problems in 9/11 Workers 3Health News:Georgetown leads major effort to combat disparities in DC stroke care 2Health News:Georgetown leads major effort to combat disparities in DC stroke care 3Health News:Trouble deciding? 2Health News:Trouble deciding? 3
    (Date:7/30/2014)... Research and Markets has announced ... Packaging Industry Report 2014" report to their offering. ... The Global and Chinese Aseptic Packaging Industry Report is ... of the global Aseptic Packaging industry with a focus ... basic overview of the industry including definitions, classifications, applications ...
    (Date:7/30/2014)... 2014  Decision Resources Group finds that ... research imaging system market will be significantly driven ... combining computed tomography and magnetic resonance imaging with ... from the need for higher-quality imaging to satisfy ... will spur preclinical imaging system sales. ...
    (Date:7/30/2014)... 2014   Unique Pizza and Subs Corporation ... UPZS), a Delaware Corporation, is pleased to announce ... Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical company that produces ... US-based Larasan will work with Unique to help ... Larasan,s vast distribution network throughout China ...
    Breaking Medicine Technology:Global and Chinese Aseptic Packaging Industry Report 2014 2Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3
    ... ASSERT Trial Presented at EULAR, BARCELONA, Spain, ... at the European League Against Rheumatism (EULAR),Annual ... with,ankylosing spondylitis (AS) who received REMICADE(R) (infliximab),over ... In addition, REMICADE-treated patients showed sustained,reductions in ...
    ... Biotech (OMX Nordic: ACTI) presented,pre-clinical results for ... (The,European League Against Rheumatism, <a target="_blank" href=,"http://www.eular.org/">www.eular.org ... pre-clinical data presented show that I-3D has ... an,experimental model for rheumatoid arthritis (RA)", commented ...
    Cached Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2
    ... System provides anterior column support for single ... T1 to L5. The system consists of ... cages that are stacked to a desired ... Carbon Fiber Reinforced Polymer material emulates the ...
    ... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
    ... Cage system is a carbon fiber reinforced ... and biologic functions of posterior lumbar interbody ... provides a device designed to meet the ... cancellous bone, the best possible bone for ...
    ... is highly adaptable and therefore suitable for ... to its extraordinary small outer diameter and ... of a simple but secure and reliable ... steering instruments around the corner. These characteristics ...
    Medicine Products: